Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.
EMBO Rep. 2021 Feb 3;22(2):e51184. doi: 10.15252/embr.202051184. Epub 2021 Jan 7.
Differentiation of naïve peripheral B cells into terminally differentiated plasma cells is characterized by epigenetic alterations, yet the epigenetic mechanisms that control B-cell fate remain unclear. Here, we identified a role for the histone H3K79 methyltransferase DOT1L in controlling B-cell differentiation. Mouse B cells lacking Dot1L failed to establish germinal centers (GC) and normal humoral immune responses in vivo. In vitro, activated B cells in which Dot1L was deleted showed aberrant differentiation and prematurely acquired plasma cell characteristics. Similar results were obtained when DOT1L was chemically inhibited in mature B cells in vitro. Mechanistically, combined epigenomics and transcriptomics analysis revealed that DOT1L promotes expression of a pro-proliferative, pro-GC program. In addition, DOT1L indirectly supports the repression of an anti-proliferative plasma cell differentiation program by maintaining the repression of Polycomb Repressor Complex 2 (PRC2) targets. Our findings show that DOT1L is a key modulator of the core transcriptional and epigenetic landscape in B cells, establishing an epigenetic barrier that warrants B-cell naivety and GC B-cell differentiation.
幼稚外周 B 细胞分化为终末分化的浆细胞的特征是表观遗传改变,但控制 B 细胞命运的表观遗传机制仍不清楚。在这里,我们确定了组蛋白 H3K79 甲基转移酶 DOT1L 在控制 B 细胞分化中的作用。缺乏 Dot1L 的小鼠 B 细胞无法在体内建立生发中心 (GC) 和正常的体液免疫反应。在体外,缺失 Dot1L 的活化 B 细胞表现出异常分化,并过早获得浆细胞特征。当 DOT1L 在体外的成熟 B 细胞中被化学抑制时,也得到了类似的结果。从机制上讲,联合表观基因组学和转录组学分析表明,DOT1L 促进了促增殖、促 GC 程序的表达。此外,DOT1L 通过维持多梳抑制复合物 2 (PRC2) 靶标的抑制,间接支持抑制抗增殖浆细胞分化程序。我们的研究结果表明,DOT1L 是 B 细胞核心转录和表观遗传景观的关键调节剂,建立了一个表观遗传障碍,保证了 B 细胞的幼稚性和 GC B 细胞的分化。